Last reviewed · How we verify
TTAX03
At a glance
| Generic name | TTAX03 |
|---|---|
| Sponsor | BioTissue Holdings, Inc |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03. (PHASE2)
- Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord (TTAX03) for KL Grade 3-4 Knee OA (PHASE2)
- TTAX03 for the Treatment of Lumbosacral Facet Joint Pain (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TTAX03 CI brief — competitive landscape report
- TTAX03 updates RSS · CI watch RSS
- BioTissue Holdings, Inc portfolio CI